Prospects of the use of prostaglandin analogues in the treatment of patients with thyroid eye disease

Melovatskiy P.D.; Krylova E.I.; Grusha Y.O.

doi:https://doi.org/10.17116/oftalma2022138052285

Melovatskiy P.D.

Research Institute of Eye Diseases

Krylova E.I.

I.M. Sechenov First Moscow State Medical University (Sechenov University)

ORCID: 0000-0002-0220-0474

Grusha Y.O.

I.M. Sechenov First Moscow State Medical University (Sechenov University);
Krasnov Research Institute of Eye Diseases

ORCID: 0000-0002-6461-8243

Prospects of the use of prostaglandin analogues in the treatment of patients with thyroid eye disease

Authors:

Melovatskiy P.D., Krylova E.I., Grusha Y.O.

More about the authors

Journal: Russian Annals of Ophthalmology. 2022;138(5‑2): 285‑288

DOI: 10.17116/oftalma2022138052285

Read: 2554 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Melovatskiy PD, Krylova EI, Grusha YO. Prospects of the use of prostaglandin analogues in the treatment of patients with thyroid eye disease. Russian Annals of Ophthalmology. 2022;138(5‑2):285‑288. (In Russ.)
https://doi.org/10.17116/oftalma2022138052285

Подписка 2026 Вестник офтальмологии (Russian Annals of Ophthalmology)

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

Approaches for improvement of ocular surface condition in primary open-angle glaucoma. Russian Annals of Ophthalmology. 2024;(5):7-16

Perioperative prevention of bleeding in glaucoma surgery. Russian Annals of Ophthalmology. 2024;(5):118-124

Glucocorticoid-resistant forms of endocrine ophthalmopathy. Russian Annals of Ophthalmology. 2024;(6):125-130

The results of fistulizing glaucoma surgeries in pseudophackic patients. Russian Annals of Ophthalmology. 2025;(1):45-52

Lower eyelid retraction after inferior rectus recession in thyroid eye disease. Russian Annals of Ophthalmology. 2025;(2):101-105

Outcomes of modified lateral orbital wall decompression using ultrasonic bone removal. Russian Annals of Ophthalmology. 2025;(4):21-28

The possibilities of antioxidant neuroretinoprotection in the treatment of primary open-angle glaucoma. Russian Annals of Ophthalmology. 2025;(4):49-59

Autologous adipose tissue in treatment of linear scleroderma in the children (literature review). Plastic Surgery and Aesthetic Medicine. 2024;(4-2):91-94

Experimental substantiation of medical device design for mechanical processing of adipose tissue. Pirogov Russian Journal of Surgery. 2024;(12-2):101-108

Standardized and scalable method for stromal-vascular fraction harvesting from adipose tissue. Regenerative Biotechnologies, Preventive, Digital and Predictive Medicine. 2024;(4):76-81

Abstract:

Currently, the only effective method of treatment and rehabilitation of patients with inactive thyroid eye disease (TED) is orbital decompression. This review analyzes the prospects of using prostaglandin analogues (PGF2β) to decrease the volume of orbital fat in order to reduce proptosis and periorbital changes in TED. Despite the fact that the available data on the results of using PGF2β analogues in patients with TED are contradictory, were based on short follow-up periods and involved only a small number of patients, we believe that this topic is a very promising avenue for further research.

Keywords:

Prostaglandin-associated periorbitopathy

thyroid eye disease

exophthalmos

adipose tissue

prostaglandins

bimatoprost

glaucoma

Authors:

Melovatskiy P.D.

Research Institute of Eye Diseases

Krylova E.I.

I.M. Sechenov First Moscow State Medical University (Sechenov University)

ORCID: 0000-0002-0220-0474

Grusha Y.O.

I.M. Sechenov First Moscow State Medical University (Sechenov University);
Krasnov Research Institute of Eye Diseases

ORCID: 0000-0002-6461-8243

Received:

22.04.2022

Accepted:

31.05.2022

Close metadata

References:

Erichev VP. Prostaglandins in ophthalmology. Vestnik oftal’mologii. 2022; 138(1):106-113. (In Russ.). https://doi.org/10.17116/oftalma2022138011106
Kucukevcilioglu M, Bayer A, Uysal Y, Altinsoy HI. Prostaglandin associated periorbitopathy in patients using bimatoprost, latanoprost and travoprost. Clinical and Experimental Ophthalmology. 2014;42(2):126-131. https://doi.org/10.1111/ceo.12163
Peplinski LS, Albiani Smith K. Deepening of lid sulcus from topical bimatoprost therapy. Optometry and Vision Science. 2004;81(8):574-577. https://doi.org/10.1097/01.opx.0000141791.16683.4a
Filippopoulos T, Paula JS, Torun N, Hatton MP, Pasquale LR, Grosskreutz CL. Periorbital changes associated with topical bimatoprost. Ophthalmic Plastic and Reconstructive Surgery. 2008;24(4):302-307. https://doi.org/10.1097/IOP.0b013e31817d81df
Choi CJ, Tao W, Doddapaneni R, Acosta-Torres Z, Blessing NW, Lee BW, Pelaez D, Wester ST. The Effect of Prostaglandin Analogue Bimatoprost on Thyroid-Associated Orbitopathy. Investigative Ophthalmology and Visual Science. 2018;59(15):5912-5923. https://doi.org/10.1167/iovs.18-25134
Draman MS, Grennan-Jones F, Zhang L, Taylor PN, Tun TK, McDermott J, Moriarty P, Morris D, Lane C, Sreenan S, Dayan C, Ludgate M. Effects of prostaglandin F(2α) on adipocyte biology relevant to graves’ orbitopathy. Thyroid. 2013;23(12):1600-1608. https://doi.org/10.1089/thy.2013.01947
Liang Y, Woodward DF, Guzman VM, Li C, Scott DF, Wang JW, Wheeler LA, Garst ME, Landsverk K, Sachs G, Krauss AH, Cornell C, Martos J, Pettit S, Fliri H. Identification and pharmacological characterization of the prostaglandin FP receptor and FP receptor variant complexes. British Journal of Pharmacology. 2008;154(5):1079-1093. https://doi.org/10.1038/bjp.2008.142
Park J, Cho HK, Moon JI. Changes to upper eyelid orbital fat from use of topical bimatoprost, travoprost, and latanoprost. Japanese Journal of Ophthalmology. 2011;55(1):22-27. https://doi.org/10.1007/s10384-010-0904-z
Luisa V, Riccardo T, Stefano P, Manlio G. Effectiveness of orbital decompression for endocrine orbitopathy and impact on quality of life: A retrospective study. Journal of Cranio-Maxillo-Facial Surgery. 2021;49(9):867-874. https://doi.org/10.1016/j.jcms.2021.03.001
Avetisov SE, Babaeva DM, Belovalova IM, Bessmertnaya EG, Vorontsov AV, Vladimirova VP, Grusha YO, Danilov SS, Zdor VV, Ismailova DS, Panteleeva OG, Petunina NA. Remizov OV, Sviridenko NYu, Tabeeva KI, Chepurina AA, Chuprik-Malinovskaya TP, Sheremeta MS. Autoimmunnaya patologiya shchitovidnoj zhelezy i endokrinnaya oftal’mopatiya. Pod red. II Dedova i GA Melnichenko. M.: Izdatel’stvo OOO «Tipografiya «Pechatnyh Del Master»; 2020. (In Russ.).
Yang HK, Park KH, Kim TW, Kim DM. Deepening of eyelid superior sulcus during topical travoprost treatment. Japanese Journal of Ophthalmology. 2009;53(2):176-179. https://doi.org/10.1007/s10384-008-0623-x
Eiger-Moscovich M, Stiebel-Kalish H, Yassur I, Barash D, Gaton D, Avisar I. Prostaglandin analogue drops for the treatment of soft tissue expansion and exophthalmos in patients with inactive thyroid eye disease. Canadian Journal of Ophthalmology. 2019;54(4):426-430. https://doi.org/10.1016/j.jcjo.2018.09.003
Higashiyama T, Ohji M. Treatment with bimatoprost for exophthalmos in patients with inactive thyroid-associated ophthalmopathy. Clinical Ophthalmology. 2018;12:2415-2421. https://doi.org/10.2147/OPTH.S187164
Draman MS, Morris DS, Evans S, Haridas A, Pell J, Greenwood R, Foy C, Taylor P, Pooprasert P, Muller I, Zhang L, Lane C, Okosieme O, Ludgate M, Dayan C. Prostaglandin F2-Alpha Eye Drops (Bimatoprost) in Graves’ Orbitopathy: A Randomized Controlled Double-Masked Crossover Trial (BIMA Trial). Thyroid. 2019;29(4):563-572. https://doi.org/10.1089/thy.2018.0506
Eftekhari K, Vagefi MR, Lee V, Hui JZ, Zhu M, Dine K, Anderson RL, Koeberlein B, Sulaimankutty R, Shindler KS. In Vivo Effects of Retrobulbar Bimatoprost Injection on Orbital Fat. Ophthalmic Plastic and Reconstructive Surgery. 2018;34(3):201-204. https://doi.org/10.1097/IOP.0000000000000907